Trailing-twelve-month (TTM) revenue is $27.70 Billion with a year-over-year growth of +6.31%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $7,078,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $7,009,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $6,517,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $7,100,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $27,704,000,000 |
Current P/S: $180,099,060,880 market capitalization ÷ $27,704,000,000 TTM revenue = 6.50x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $7.10B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| High-Growth Markets | $9.6B | $12.2B | $11.3B | $12.4B | $12.6B | $13.6B |
| International Developmental Licensed Markets and Corporate | $1.8B | $2.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| International Developmental Licensed Markets and Corporate | $1.8B | $2.1B | $2.3B | $2.5B | $2.7B | $2.4B |
| International Operated Markets | $9.6B | $12.2B |
$27.70B
$27.70 Billion
+6.31%
vs. $26.06B a year ago (TTM)
+4.96%
5 Year compound annual growth rate
1 Year
+6.31%
3 Year
+4.62%
5 Year
+4.96%
10 Year
+0.98%
15 Year
+0.54%
20 Year
+1.43%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $26.89B | +$965.00M | +3.72% |
| 2024 | $25.92B | +$425.00M | +1.67% |
| 2023 | $25.50B | +$2.31B | +9.98% |
| 2022 | $23.18B | ($40.90M) | (0.18%) |
| 2021 | $23.22B | +$4.02B | +20.90% |
| 2020 |
TTM Growth
+6.31%
3-Year CAGR
+4.62%
5-Year CAGR
+4.96%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.5B |
| $2.7B |
| $2.4B |
| UNITED STATES | $7.8B | $8.9B | $9.6B | $10.6B | $10.6B | $10.8B |
|---|
| $12.4B |
| $12.6B |
| $13.6B |
| UNITED STATES | $7.8B | $8.9B | $9.6B | $10.6B | $10.6B | $10.8B |
|---|
| $19.21B |
| ($2.16B) |
| (10.09%) |
| 2019 | $21.36B | +$106.50M | +0.50% |
| 2018 | $21.26B | ($1.56B) | (6.85%) |
| 2017 | $22.82B | ($1.80B) | (7.32%) |
| 2016 | $24.62B | ($791.10M) | (3.11%) |
